Pateclizumab
From Wikipedia, the free encyclopedia
Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Humanized |
Target | lymphotoxin alpha |
Clinical data | |
Legal status | ? |
Identifiers | |
CAS number | 1202526-59-7 |
ATC code | None |
KEGG | D10187 |
Chemical data | |
Formula | ? |
(what is this?) (verify) | |
Pateclizumab is an immunomodulator. It binds to lymphotoxin alpha.[1]
References
- ↑ World Health Organization (2011). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 105" (PDF). WHO Drug Information 25 (2).
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.